{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:42:15Z","timestamp":1793673735205,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymthe.2024.12.019","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T19:22:30Z","timestamp":1734031350000},"page":"2872-2885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8183-3490","authenticated-orcid":false,"given":"Hong-My","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah C.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5100-6289","authenticated-orcid":false,"given":"Mitchell","family":"Thorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.12.019_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41525-023-00387-4","article-title":"Breaking the mold with RNA-a \"RNAissance\" of life science","volume":"9","author":"Jones","year":"2024","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.ymthe.2024.12.019_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/d41573-023-00002-2","article-title":"The landscape for lipid-nanoparticle-based genomic medicines","volume":"22","author":"Verma","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.12.019_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igyarto","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib5","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.12.019_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010830","article-title":"Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion","volume":"18","author":"Qin","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2024.12.019_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1336906","article-title":"The mRNA-LNP vaccines - the good, the bad and the ugly?","volume":"15","author":"Igyarto","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032700","article-title":"A Comprehensive Review of mRNA Vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.12.019_bib9","series-title":"Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products","first-page":"35","author":"US Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.ymthe.2024.12.019_bib10","doi-asserted-by":"crossref","first-page":"16151","DOI":"10.1021\/acsnano.4c01171","article-title":"High-Throughput In Vivo Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route","volume":"18","author":"Hamilton","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2024.12.019_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.omtm.2023.06.005","article-title":"Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues","volume":"30","author":"Chander","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.12.019_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/pharmaceutics16060771","article-title":"Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy","volume":"16","author":"Gambaro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2024.12.019_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713364","article-title":"CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo","volume":"24","author":"Golubovskaya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.12.019_bib15","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1038\/s41467-023-42672-x","article-title":"Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropism","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.12.019_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.1000325","article-title":"Dendritic cell apoptosis: regulation of tolerance versus immunity","volume":"185","author":"Kushwah","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-023-00733-8","article-title":"mRNA-LNP vaccination-based immunotherapy augments CD8(+) T cell responses against HPV-positive oropharyngeal cancer","volume":"8","author":"Qiu","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2024.12.019_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.019_bib19","article-title":"mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions","author":"Bakos","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.12.019_bib20","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2024.12.019_bib21","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.12.019_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2144\/btn-2022-0024","article-title":"High Transfection Efficiency and Cell Viability of Immune Cells with Nanomaterials-Based Transfection Reagent","volume":"72","author":"Wang","year":"2022","journal-title":"BioTechniques"},{"key":"10.1016\/j.ymthe.2024.12.019_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/15476286.2020.1730081","article-title":"Transfection of hard-to-transfect primary human macrophages with Bax siRNA to reverse Resveratrol-induced apoptosis","volume":"17","author":"Dong","year":"2020","journal-title":"RNA Biol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jconrel.2022.03.033","article-title":"Delivery of mRNA for regulating functions of immune cells","volume":"345","author":"Shi","year":"2022","journal-title":"J. Control Release."},{"key":"10.1016\/j.ymthe.2024.12.019_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122097","article-title":"Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles","volume":"13","author":"Tanaka","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2024.12.019_bib26","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tombacz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.12.019_bib27","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.12.019_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1039\/D2BM01581A","article-title":"Lipid nanoparticle-based mRNA candidates elicit potent T cell responses","volume":"11","author":"Zeng","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ymthe.2024.12.019_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.medj.2024.02.008","article-title":"The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccination","volume":"5","author":"Tsang","year":"2024","journal-title":"Med."},{"key":"10.1016\/j.ymthe.2024.12.019_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2147\/IDR.S348392","article-title":"The Potential Predictive Role of Tumour Necrosis Factor-alpha, Interleukin-1beta, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival","volume":"15","author":"Kumboyono","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ymthe.2024.12.019_bib31","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/ar3549","article-title":"Tumor necrosis factor alpha release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients","volume":"14","author":"Nabatian","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ymthe.2024.12.019_bib32","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.76.22.11710-11714.2002","article-title":"Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha","volume":"76","author":"De","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jbm.a.37356","article-title":"Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery","volume":"110","author":"Zhang","year":"2022","journal-title":"J. Biomed. Mater. Res. A."},{"key":"10.1016\/j.ymthe.2024.12.019_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-gamma, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.12.019_bib35","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/SLA.0b013e31828dfbf1","article-title":"Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories","volume":"259","author":"Jeschke","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ymthe.2024.12.019_bib36","article-title":"Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications","volume":"35","author":"Lam","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2024.12.019_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s42003-023-04555-1","article-title":"Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals","volume":"6","author":"Connors","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2024.12.019_bib38","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.ymthe.2022.07.007","article-title":"mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells","volume":"30","author":"Bevers","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.12.019_bib39","article-title":"Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice","volume":"12","author":"Bonam","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.12.019_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kel061","article-title":"Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus","volume":"45","author":"Decker","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymthe.2024.12.019_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006600","article-title":"Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis","volume":"4","author":"Nolan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.12.019_bib42","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: systemic lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymthe.2024.12.019_bib43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.12.019_bib44","article-title":"Increased FAN1 expression by mRNA-LNP attenuates CAG repeat expansion in Huntington patients\u2019 iPSC-derived astrocytes","author":"Cheng","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.12.019_bib45","article-title":"Targeting ABCB4 using mRNA-LNP for the treatment of rare liver diseases","author":"Alsuraih","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.12.019_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.122.001452","article-title":"A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6(+) T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation","volume":"386","author":"Li","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624008189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624008189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T21:13:30Z","timestamp":1759612410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624008189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1525001624008189"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}